A phase I trial of repeated tumour-infiltrating lymphocyte (TIL) infusion in metastatic melanoma (Q36080365)

12 August 2017

A phase I trial of repeated tumour-infiltrating lymphocyte (TIL) infusion in metastatic melanoma (English)

1 reference

12 August 2017

phase I clinical trial

0 references

1 reference

Ravaud A

1

1 reference

12 August 2017

Legrand E

2

1 reference

12 August 2017

Delaunay MM

3

1 reference

12 August 2017

Bussières E

4

1 reference

12 August 2017

Coulon V

5

1 reference

12 August 2017

Cany L

6

1 reference

12 August 2017

Huet S

7

1 reference

12 August 2017

Verdier D

8

1 reference

12 August 2017

Kind M

9

1 reference

12 August 2017

Chomy F

10

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 February 1995

1 reference

British Journal of Cancer

12 August 2017

1 reference

12 August 2017

71

1 reference

12 August 2017

2

1 reference

12 August 2017

331-336

1 reference

Potential applications of the interferons in oncology: lessons drawn from studies of human melanoma.

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033579

Autologous tumor-specific cytotoxic T lymphocytes in the infiltrate of human metastatic melanomas. Activation by interleukin 2 and autologous tumor cells, and involvement of the T cell receptor

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033579

Specific release of cytokines by lymphocytes infiltrating human melanomas in response to shared melanoma antigens.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033579

Hemodynamic effects of the administration of tumor-infiltrating lymphocytes to cancer patients.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033579

In vivo antitumor activity of tumor-infiltrating lymphocytes expanded in recombinant interleukin-2.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033579

Expansion of human tumor infiltrating lymphocytes for use in immunotherapy trials

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033579

Identification of specific cytolytic immune responses against autologous tumor in humans bearing malignant melanoma.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033579

Cachectin/tumor necrosis factor: production, distribution, and metabolic fate in vivo

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033579

Proliferative and/or cytotoxic activity of lymphocyte clones to autologous human melanoma

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033579

Clinical results and characterization of tumor-infiltrating lymphocytes with or without recombinant interleukin 2 in human metastatic renal cell carcinoma.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033579

Tumor localization of adoptively transferred indium-111 labeled tumor infiltrating lymphocytes in patients with metastatic melanoma

11 July 2018

1 reference

12 December 2020

Tumour-infiltrating lymphocytes and interleukin-2 in treatment of advanced cancer

1 reference

12 December 2020

Tumor-specific cytolysis by lymphocytes infiltrating human melanomas

1 reference

12 December 2020

Experience with the use of high-dose interleukin-2 in the treatment of 652 cancer patients

1 reference

12 December 2020

Specific release of granulocyte-macrophage colony-stimulating factor, tumor necrosis factor-alpha, and IFN-gamma by human tumor-infiltrating lymphocytes after autologous tumor stimulation

1 reference

12 December 2020

Lack of effect of tumour infiltrating lymphocytes in patients with metastatic melanoma who failed to respond to interleukin 2

1 reference

12 December 2020

Cardiomyopathy after acute myocardial infarction after therapy with interleukin-2 and tumour infiltrating lymphocytes

1 reference

12 December 2020

Histopathological analysis of metastatic melanoma deposits in patients receiving adoptive immunotherapy with tumor-infiltrating lymphocytes

1 reference

12 December 2020

Tumor-derived interleukin-2-dependent lymphocytes in adoptive immunotherapy of lung cancer

1 reference

12 December 2020

Immunotherapy of patients with advanced cancer using tumor-infiltrating lymphocytes and recombinant interleukin-2: a pilot study

1 reference

12 December 2020

Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1995.66

1 reference

Dimensions Publication ID

12 August 2017

0 references

1 reference

12 August 2017

PubMed publication ID

7530984

1 reference